BridgeBio Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
BridgeBio Pharma has entered a voluntary agreement with the U.S. government aimed at expanding access to its medicines, such as Attruby®, for rare genetic diseases under Medicaid and lowering drug costs without imposing future pricing mandates. The agreement builds on existing patient support programs and seeks to balance affordability with continu…